.png)
_(1).png){kind=logo}
Hubungan Stadium Hipertensi dengan Derajat Perlemakan Menggunakan Indeks Hepatorenal Sonografi
Abstract
Hipertensi merupakan prekursor perkembangan perlemakan hati nonalkoholik. Modalitas pencitraan USG paling banyak digunakan untuk menegakkan diagnosis perlemakan hati nonalkoholik. Saat ini dikembangkan teknik USG menggunakan parameter indeks hepatorenal sonografi yang dihitung dengan program software ImageJ dan digunakan untuk memprediksi derajat perlemakan hati. Penelitian ini bertujuan mengetahui hubungan antara stadium hipertensi dan derajat perlemakan hati nonalkoholik menggunakan indeks hepatorenal sonografi. Penelitian menggunakan studi observasional analitik dengan rancangan cross sectional, pengambilan sampel dilakukan secara consecutive admission. Penelitian dilaksanakan di Bagian Radiologi RSUP Dr. Hasan Sadikin Bandung periode Juni–Agustus 2016. Subjek penelitian 50 orang, laki-laki 22 orang, perempuan 28 orang, usia termuda 25 tahun, dan tertua 77 tahun. Hasil penelitian melalui uji statistik chi-square menunjukkan derajat perlemakan hati nonalkoholik ringan lebih banyak pada prehipertensi (9 dari 16), derajat sedang pada hipertensi stadium I (10 dari 19), dan derajat berat pada hipertensi stadium II (8 dari 15) dengan p<0,001. Perlemakan hati nonalkoholik derajat sedang dan berat lebih sering ditemukan pada perempuan dengan hipertensi (p=0,005) Simpulan, terdapat hubungan antara stadium hipertensi dan derajat perlemakan hati nonalkoholik menggunakan indeks hepatorenal sonografi.
THE ASSOCIATION OF HYPERTENSION STAGE AND NON-ALCOHOLIC FATTY LIVER DEGREE USING HEPATORENAL SONOGRAPHY INDEX
Hypertension is considered as a precursor to the development of non-alcoholic fatty liver disease (NAFLD). Ultrasonography techniques have been developed using sonography hepatorenal index parameter calculated by ImageJ, that can predict the degree of NAFLD. This study aim to determine the relationship between hypertension stage and the degree of NAFLD using sonography hepatorenal index. The research is an observational using cross sectional methods, with consecutive admission sampling method. The study was performed at Dr. Hasan Sadikin Hospital Bandung from June to August 2016. A total of 50 subjects, 22 men and 28 women, with the youngest 25 and the oldest 77 years old participated. Results indicated that the mild degree of NAFLD were higher on prehypertension (9 of 16), the moderate degree on stage I hypertension (10 of 19), while the severe degree found on stage II hypertension (8 of 15), with p<0.001. Moderate and severe degree of NAFLD in hypertensive patient is more common in women (p=0.005). In conclusion, there was a relationship between hypertension stage and the degree of NAFLD.
Keywords
Full Text:
PDFReferences
Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155–61.
Michopoulos S, Chouzouri VI, Manios ED, Grapsa E, Antoniou Z, Papadimitriou CA, dkk. Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. Clin Exp Gastroenterol. 2016;9:1–9.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, dkk. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Am J Gastroenterol. 2012;107(6):811–26.
van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, dkk. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256(1):159–68.
Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, dkk. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013;178(1):38–45.
Ryoo JH, Suh YJ, Shin HC, Cho YK, Choi JM, Park SK. Clinical association between non-alcoholic fatty liver disease and the development of hypertension. J Gastroenterol Hepatol. 2014;29(11):1926–31.
Kjeldsen S, Feldman RD, Lisheng L, Mourad JJ, Chiang CE, Zhang W, dkk. Updated national and international hypertension guidelines: a review of current recommendations. Drugs. 2014;74(17):2033–51.
Wei Q, Sun J, Huang J, Zhou HY, Ding YM, Tao YC, dkk. Prevalence of hypertension and associated risk factors in Dehui city of Jilin province in China. J Hum Hypertens. 2015;29(1):64–8.
Bell K, Twiggs J, Olin BR. Hypertension: the silent killer: updated JNC-8 guideline recommendations. June 2015 [diunduh 26 Mei 2016]. Tersedia dari: https://c.ymcdn.com/sites/www.aparx.org/resource/resmgr/CEs/CE_Test_Hypertension_The_Sil.pdf.
Kementerian Kesehatan Republik Indonesia. Profil kesehatan Indonesia 2011. Jakarta: Kemenkes RI; 2012.
Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015;7(11):1450–9.
Brookes MJ, Cooper BT. Hypertension and fatty liver: guilty by association? J Hum Hypertens. 2007;21(4):264–70.
Manrique C, Lastra G, Gardner M, Sowers JR. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am. 2009;93(3):569–82.
Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(23):7392–402.
Singh D, Das CJ, Baruah MP. Imaging of non alcoholic fatty liver disease: a road less travelled. Indian J Endocrinol Metab. 2013;17(6):990–5.
von Volkmann HL, Havre RF, Løberg EM, Haaland T, Immervoll H, Haukeland JW, dkk. Quantitative measurement of ultrasound attenuation and hepato-renal index in non-alcoholic fatty liver disease. Med Ultrason. 2013;15(1):16–22.
Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound. 2013;41(1):18–25.
Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, dkk. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR. 2009;192(4):909–14.
Marshall RH, Eissa M, Bluth EI, Gulotta PM, Davis NK. Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR. 2012;199(5):997–1002.
Soder RB, Baldisserotto M, Duval da Silva V. Computer-assisted ultrasound analysis of liver echogenicity in obese and normal-weight children. AJR. 2009;192(5):W201–5.
Martin-Rodriguez JL, Arrebola JP, Jimenez-Moleon JJ, Olea N, Gonzalez-Calvin JL. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J Gastroenterol Hepatol. 2014;26(1):88–94.
Pusat Data dan Informasi Kementerian Kesehatan RI. Hipertensi [diunduh 28 Mei 2016]. Tersedia dari: http://www.depkes.go.id/resources/download/pusdatin/infodatin/infodatin-hipertensi.pdf.
Ramdhani R, Respati T, Irasanti SK. Karakteristik dan gaya hidup pasien hipertensi di Rumah Sakit Al-Islam Bandung. GMHC. 2013;1(2):63–8.
Achmad C, Martanto E, Aprami TM, Purnomowati A, Soedjana Ningrat RRF, Febrianora M. Indeks massa ventrikel kiri dengan disfungsi diastole pada pasien konsentrik penyakit jantung hipertensi. GMHC. 2017;5(1):70–6.
Wang Z, Xu M, Hu Z, Shrestha UK, Prevalence of nonalkoholik fatty liver disease and its metabolic risk factor in women of different ages and body mass index. Pub Med. 2015;6:667–73.
Pan JJ, Fallon MB, Gender and racial differences in nonalkoholik fatty liver disease. World J Hepatol. 2014;6(5):274–83.
Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, dkk. Pediatric nonalcoholic fatty liver disease: a clinical and laboratory challenge. World J Hepatol. 2010;2(7):275–88.
DOI: https://doi.org/10.29313/gmhc.v5i3.2175
pISSN 2301-9123 | eISSN 2460-5441
Visitor since 19 October 2016:
_(1).jpg){kind=logo}
Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.